insights_auto
Outlook: 63.3% bullish·3.3% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.44
arrow_downward
-1.18%(-0.017) 1D
Nov 13, 2:15:16 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.44
High
$1.48
Low
$1.39
Mkt. cap
270.25M
Avg. vol.
19.26M
Volume
3.51M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
Open
$1.44
High
$1.48
Low
$1.39
Mkt. cap
270.25M
Avg. vol.
19.26M
Volume
3.51M
52-wk high
$2.72
52-wk low
$0.57
EPS
-$0.80
Beta
1.71
Shares outstanding
187.31M
No. of employees
112
News stories
From web sources and news partners
Seeking Alpha
·
1 hour ago
Inovio Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:INO) 2026-11-13
News Corp
·
21 hours ago
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
·
21 hours ago
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
GuruFocus
·
1 day ago
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
CEOJacqueline Shea
Employees112
Founded1999
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteinovio.com